Healthcare Sector Insider Trading Activity

Track insider buying and selling in Healthcare stocks. See which executives are buying, net insider activity, and % of float traded across 3,445 companies.
The information provided in this screen is for informational purposes only and does not constitute financial advice. We do not endorse any specific investment based on these criteria.
Companies
Data
Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Healthcare Services Mid (3.6bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (3.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.5bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (3.5bn) 0 No activity — 0–15%
Healthcare Services Mid (3.5bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (3.5bn) -1–5 -< $100K -0–15% 0–15%
IN Dr. Lal PathLabs Ltd (LALPATHLAB)
Healthcare Services Mid (3.4bn) -6–10 -$100K–$1M -0–15% 50%+
Healthcare Services Mid (3.4bn) 0 No activity — 0–15%
Healthcare Services Mid (3.4bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (3.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.4bn) 0 No activity — 50%+
Healthcare Services Mid (3.3bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (3.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.3bn) 1–5 $1M–$10M 0–15% 0–15%
Healthcare Services Mid (3.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.2bn) 0 No activity — 0–15%
FR Virbac SA (VIRP)
Pharmaceuticals & Medical Research Mid (3.2bn) 0 No activity — 50%+
US Zai Lab Ltd (9688)
Pharmaceuticals & Medical Research Mid (3.2bn) 0 No activity — 0–15%
SE BioArctic AB (BIOA-B)
Pharmaceuticals & Medical Research Mid (3.2bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (3.2bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (3.2bn) 1–5 < $100K 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.2bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (3.2bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (3.2bn) -1–5 -$100M+ -50%+ 50%+
Pharmaceuticals & Medical Research Mid (3.1bn) 0 No activity — 0–15%
Healthcare Services Mid (3.1bn) 0 No activity — —
Healthcare Services Mid (3.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (3.1bn) 0 No activity — 50%+
Healthcare Services Mid (3.1bn) 1–5 $100K–$1M 0–15% 50%+
Healthcare Services Mid (3.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.0bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (3.0bn) 0 No activity — 0–15%
Healthcare Services Mid (3.0bn) 0 $100K–$1M 0–15% 50%+
Healthcare Services Mid (3.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.0bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (3.0bn) -1–5 -$100K–$1M -0–15% 0–15%
US Xencor Inc (XNCR)
Pharmaceuticals & Medical Research Mid (3.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (2.9bn) -1–5 -< $100K -0–15% 0–15%
Healthcare Services Mid (2.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.9bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (2.9bn) 0 No activity — 50%+
Healthcare Services Mid (2.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.9bn) 0 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.9bn) 0 No activity — 15–50%
SE Cellink AB (CLNK-B)
Healthcare Services Mid (2.9bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (2.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (2.8bn) 0 No activity — 0–15%
IN Laurus Labs Ltd (LAURUSLABS)
Pharmaceuticals & Medical Research Mid (2.8bn) 0 No activity — 15–50%
Healthcare Services Mid (2.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.8bn) 0 No activity — 0–15%
Healthcare Services Mid (2.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.7bn) 0 No activity — —
Pharmaceuticals & Medical Research Mid (2.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.7bn) 0 No activity — 0–15%
US Neogen Corp (NEOG)
Healthcare Services Mid (2.7bn) 0 -$100K–$1M -0–15% 0–15%
US Progyny Inc (PGNY)
Healthcare Services Mid (2.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (2.7bn) -6–10 -$1M–$10M -0–15% 0–15%
DE Synlab AG (SYAB)
Healthcare Services Mid (2.6bn) 0 No activity — —
Healthcare Services Mid (2.6bn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Mid (2.6bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (2.6bn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (2.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.6bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.5bn) 0 No activity — 15–50%
Healthcare Services Mid (2.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.5bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (2.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.5bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (2.5bn) 0 No activity — 0–15%
Healthcare Services Mid (2.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.5bn) 0 No activity — 0–15%
IN Pfizer Ltd (PFIZER)
Pharmaceuticals & Medical Research Mid (2.5bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (2.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (2.4bn) 0 No activity — 15–50%
Healthcare Services Mid (2.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.4bn) -6–10 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (2.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.4bn) 0 No activity — 0–15%
DK Ambu A/S (AMBU-B)
Healthcare Services Mid (2.4bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (2.3bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (2.3bn) 0 No activity — 50%+
Healthcare Services Mid (2.3bn) -6–10 -$10M–$100M -0–15% 0–15%
US Premier Inc (PINC)
Healthcare Services Mid (2.3bn) 0 No activity — 0–15%
Healthcare Services Mid (2.3bn) 0 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (2.3bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.3bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (2.3bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (2.3bn) 0 No activity — —
Pharmaceuticals & Medical Research Mid (2.3bn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.3bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (2.3bn) 0 No activity — 0–15%
Loading...